San Francisco Sentry Investment Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-100
Closed -$27K 630
2014
Q1
$27K Hold
100
0.01% 421
2013
Q4
$36K Hold
100
0.01% 369
2013
Q3
$53K Hold
100
0.02% 298
2013
Q2
$23K Buy
+100
New +$23K 0.01% 402